{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T02:28:16Z","timestamp":1791599296675,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":1620,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jlr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1194\/jlr.r051870","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T05:51:17Z","timestamp":1450504277000},"page":"917-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis"],"prefix":"10.1016","volume":"57","author":[{"given":"George","family":"Thanassoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.R051870_bib1","first-page":"362","article-title":"Prevalence, referral patterns, testing, and surgery in aortic valve disease: leaving women and elderly patients behind?","volume":"16","author":"Bach","year":"2007","journal-title":"J. Heart Valve Dis."},{"key":"10.1194\/jlr.R051870_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIR.0000000000000157","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib3","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","article-title":"Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R051870_bib4","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib5","first-page":"e28","article-title":"Heart disease and stroke statistics\u20132014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0735-1097(93)90249-Z","article-title":"Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample","volume":"21","author":"Lindroos","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/01.ATV.16.4.523","article-title":"Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of \u2018degenerative\u2019 valvular aortic stenosis","volume":"16","author":"O'Brien","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R051870_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1161\/01.CIR.90.2.844","article-title":"Characterization of the early lesion of \u2018degenerative\u2019 valvular aortic stenosis. Histological and immunohistochemical studies","volume":"90","author":"Otto","year":"1994","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib11","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.jacc.2010.03.019","article-title":"Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium","volume":"55","author":"Thanassoulis","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib12","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1161\/CIRCRESAHA.110.234245","article-title":"The roles of lipid oxidation products and receptor activator of nuclear factor-kappaB signaling in atherosclerotic calcification","volume":"108","author":"Demer","year":"2011","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R051870_bib13","doi-asserted-by":"crossref","unstructured":"., Kvidal, P., R. Bergstrom, L-G. Horte, and E. Stahle, . 2000. Observed and relative survival after aortic valve replacement. J. Am. Coll. Cardiol. 35: 747\u2013756.","DOI":"10.1016\/S0735-1097(99)00584-7"},{"key":"10.1194\/jlr.R051870_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"ASTRONOMER Investigators. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib15","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib18","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0002-9149(99)80263-X","article-title":"Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study)","volume":"76","author":"Gotoh","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.R051870_bib19","first-page":"387","article-title":"Effects of serum levels of novel atherosclerotic risk factors on aortic valve calcification","volume":"16","author":"Bozbas","year":"2007","journal-title":"J. Heart Valve Dis."},{"key":"10.1194\/jlr.R051870_bib20","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0195-668X(02)00385-8","article-title":"Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis","volume":"24","author":"Glader","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.R051870_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/MOL.0b013e3282f73893","article-title":"\u2018Deep phenotyping\u2019: characterizing populations in the era of genomics and systems biology","volume":"19","author":"Tracy","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.R051870_bib23","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cjca.2012.09.014","article-title":"Mendelian randomization: how genetics is pushing the boundaries of epidemiology to identify new causes of heart disease","volume":"29","author":"Thanassoulis","year":"2013","journal-title":"Can. J. Cardiol."},{"key":"10.1194\/jlr.R051870_bib25","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.2009.812","article-title":"Mendelian randomization: nature's randomized trial in the post-genome era","volume":"301","author":"Thanassoulis","year":"2009","journal-title":"JAMA."},{"key":"10.1194\/jlr.R051870_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet."},{"key":"10.1194\/jlr.R051870_bib28","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.jacc.2015.07.020","article-title":"Oxidized phospholipids, lipoprotein(a), and progression of calcific aortic valve stenosis","volume":"66","author":"Capoulade","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.RES.78.4.615","article-title":"Specific accumulation of lipoprotein(a) in balloon-injured rabbit aorta in vivo","volume":"78","author":"Nielsen","year":"1996","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R051870_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/CIRCRESAHA.110.223875","article-title":"Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity","volume":"108","author":"Miller","year":"2011","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R051870_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.R051870_bib32","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1194\/jlr.M036343","article-title":"MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma","volume":"54","author":"Wiesner","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R051870_bib33","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/CIRCULATIONAHA.111.051599","article-title":"Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses","volume":"124","author":"Ketelhuth","year":"2011","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa043175","article-title":"Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease","volume":"353","author":"Tsimikas","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.R051870_bib35","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1194\/jlr.M800174-JLR200","article-title":"A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma","volume":"49","author":"Bergmark","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.R051870_bib36","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.108.836940","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race\/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study","volume":"119","author":"Tsimikas","year":"2009","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib37","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib39","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science."},{"key":"10.1194\/jlr.R051870_bib40","unstructured":"Deleted in proof."},{"key":"10.1194\/jlr.R051870_bib41","doi-asserted-by":"crossref","first-page":"12010","DOI":"10.1073\/pnas.96.21.12010","article-title":"Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils","volume":"96","author":"Leitinger","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.R051870_bib42","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.ATV.20.10.2248","article-title":"Determinants of bioactivity of oxidized phospholipids. Specific oxidized fatty acyl groups at the sn-2 position","volume":"20","author":"Subbanagounder","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R051870_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCRESAHA.108.181040","article-title":"Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2","volume":"104","author":"Bae","year":"2009","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.R051870_bib44","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF00308315","article-title":"Colocalization of cholesterol and hydroxyapatite in human atherosclerotic lesions","volume":"52","author":"Hirsch","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1194\/jlr.R051870_bib45","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0891-5849(01)00610-4","article-title":"Oxidative stress modulates osteoblastic differentiation of vascular and bone cells","volume":"31","author":"Mody","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1194\/jlr.R051870_bib46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.107.156745","article-title":"Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification","volume":"28","author":"Liberman","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R051870_bib47","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0092-8674(00)80257-3","article-title":"Osf2\/Cbfa1: a transcriptional activator of osteoblast differentiation","volume":"89","author":"Ducy","year":"1997","journal-title":"Cell."},{"key":"10.1194\/jlr.R051870_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation: a possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.R051870_bib49","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jacc.2013.05.105","article-title":"Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization","volume":"63","author":"Mahmut","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib50","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.freeradbiomed.2011.08.026","article-title":"Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2","volume":"51","author":"Kadl","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1194\/jlr.R051870_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacc.2008.09.052","article-title":"Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2","volume":"53","author":"Yang","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.115.016757","article-title":"Autotaxin derived from lipoprotein(a) and valve interstitial cells promotes inflammation and mineralization of the aortic valve","volume":"132","author":"Bouchareb","year":"2015","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cjca.2011.03.012","article-title":"Lipid lowering on progression of mild to moderate aortic stenosis: meta-analysis of the randomized placebo-controlled clinical trials on 2344 patients","volume":"27","author":"Teo","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"10.1194\/jlr.R051870_bib54","doi-asserted-by":"crossref","unstructured":"Mundy, G., R. Garrett, S. Harris, J. Chan, D. Chen, G. Rossini, B. Boyce, M. Zhao, and G. Gutierrez, . 1999. Stimulation of bone formation in vitro and in rodents by statins. Science. 286: 1946\u20131949.","DOI":"10.1126\/science.286.5446.1946"},{"key":"10.1194\/jlr.R051870_bib55","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2014.13959","article-title":"Association of low-density lipoprotein cholesterol-related genetic variants with aortic valve calcium and incident aortic stenosis","volume":"312","author":"Smith","year":"2014","journal-title":"JAMA."},{"key":"10.1194\/jlr.R051870_bib56","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jacc.2010.10.052","article-title":"Antisense oligonucleotide lowers plasma levels of apolipoprotein (a) and lipoprotein (a) in transgenic mice","volume":"57","author":"Merki","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib57","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1194\/jlr.R051870_bib58","doi-asserted-by":"crossref","unstructured":"Graham, M. J., N. Viney, R. Crooke, and S. Tsimikas, . Antisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humans. J. Lipid Res. Epub ahead of print. November 4, 2015; doi:10.1194\/jlr.R052258.","DOI":"10.1194\/jlr.R052258"},{"key":"10.1194\/jlr.R051870_bib59","unstructured":"Thanassoulis, G., 2015. Early Aortic Valve Lipoprotein(a) Lowering Trial (EAVaLL). Accessed December 11, 2015, at https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02109614."},{"key":"10.1194\/jlr.R051870_bib60","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet."},{"key":"10.1194\/jlr.R051870_bib61","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/CIRCIMAGING.113.001508","article-title":"18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis","volume":"7","author":"Dweck","year":"2014","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1194\/jlr.R051870_bib62","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/CIRCULATIONAHA.111.051052","article-title":"Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis","volume":"125","author":"Dweck","year":"2012","journal-title":"Circulation."},{"key":"10.1194\/jlr.R051870_bib17","unstructured":"Deleted in proof."},{"key":"10.1194\/jlr.R051870_bib38","unstructured":"Deleted in proof."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520351713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520351713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.R051870","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:51:46Z","timestamp":1637434306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520351713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0022227520351713"],"URL":"https:\/\/doi.org\/10.1194\/jlr.r051870","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1194\/jlr.R051870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}